Calamos Advisors
ARRY

Calamos Advisors’s Array Biopharma Inc ARRY Stock Holding History

Calamos Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-163,651
Closed -$7.58M – 816
2019
Q2 		$7.58M Buy
+163,651
New +$4.59M 0.04% 408

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Calamos Advisors's ARRY Position: Q3 2019 in Review

Calamos Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 163,651 shares — an estimated $7.58M sold.

Calamos Advisors first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $7.58M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Calamos Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Calamos Advisors sold 163,651 Array Biopharma Inc shares in Q3 2019, an estimated $7.58M.
  • Calamos Advisors first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Calamos Advisors's Array Biopharma Inc position peaked at $7.58M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Calamos Advisors's 13F filing for Q3 2019, filed 21 Oct 2019.